Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations

PaperCitations, authors & open-access status

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 3,210 citations, 2013 year and closed oa status.

3,210
Citations
2013
Year
closed
OA Status

Related on ScholarIQ

Lecia V. Sequist
Author
Nobuyuki Yamamoto
Author
James Chih‐Hsin Yang
Author
Journal of Clinical Oncology
Journal
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
470M+ articles · free account